PubRank

M Sharpe

Author PubWeight™ 130.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011 10.73
2 Functional somatic syndromes: one or many? Lancet 1999 7.48
3 Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995 5.91
4 Psychological autopsy studies of suicide: a systematic review. Psychol Med 2003 4.97
5 Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000 2.89
6 Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med 2013 2.82
7 Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry 2000 2.52
8 Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest. Neurology 2008 2.44
9 Treating medically unexplained physical symptoms. BMJ 1997 2.27
10 Putting the rest cure to rest--again. BMJ 1998 2.19
11 Systemic family therapy in adult psychiatry. A review of 50 families. Br J Psychiatry 1991 2.03
12 Depression after stroke and lesion location: a systematic review. Lancet 2000 1.87
13 GP frequent consulters: their prevalence, natural history, and contribution to rising workload. Br J Gen Pract 1998 1.78
14 The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003 1.78
15 Frequent consulters in general practice: a systematic review of studies of prevalence, associations and outcome. J Psychosom Res 1999 1.70
16 Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011 1.69
17 Suicidal ideation among outpatients at general neurology clinics: prospective study. BMJ 2000 1.54
18 Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991 1.54
19 Health protection net. Can J Infect Dis 1994 1.52
20 Chronic fatigue syndrome: a cognitive approach. Behav Res Ther 1995 1.52
21 What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry 2001 1.51
22 The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003 1.48
23 Frequent medical absences in secondary school students: survey and case-control study. Arch Dis Child 2009 1.48
24 Diagnosis, disease and illness. QJM 1995 1.39
25 The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003 1.36
26 The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs 2011 1.35
27 Negative attitudes among short-term stroke survivors predict worse long-term survival. Stroke 2001 1.34
28 Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ 1993 1.29
29 The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev 2007 1.25
30 Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry 2005 1.23
31 Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer 2011 1.19
32 Prevalence of depression in adults with cancer: a systematic review. Ann Oncol 2012 1.19
33 Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study. Br J Cancer 2007 1.19
34 Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use. Gen Hosp Psychiatry 1999 1.14
35 A quantitative study of the emotional outcome of people caring for stroke survivors. Stroke 1998 1.12
36 Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Symp Soc Exp Biol 1993 1.10
37 Health-related quality of life in patients with chronic fatigue syndrome: an international study. J Psychosom Res 2001 1.10
38 Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001 1.10
39 Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010 1.08
40 Psychosomatic medicine and evidence-based treatment. J Psychosom Res 1996 1.07
41 Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain 2009 1.06
42 EMG and strength correlates of selected shoulder muscles during rotations of the glenohumeral joint. Clin Biomech (Bristol, Avon) 2000 1.06
43 Patients whom neurologists find difficult to help. J Neurol Neurosurg Psychiatry 2004 1.04
44 Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep? Psychosom Med 1998 1.04
45 Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2002 1.02
46 Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev 2008 1.01
47 Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy. Ann Oncol 2011 1.01
48 Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man. Hum Reprod Update 2001 1.00
49 Distress and concerns in couples referred to a specialist infertility clinic. J Psychosom Res 2003 0.98
50 Fatty acids stimulate activity and restore respiratory control in a proton channel mutant of cytochrome c oxidase. FEBS Lett 1996 0.97
51 Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005 0.96
52 Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidity. J Behav Med 2001 0.95
53 Does undergraduate education have an effect on Edinburgh medical students' attitudes to psychiatry and psychiatric patients? J Nerv Ment Dis 1999 0.93
54 Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: a case-control study. Psychol Med 2011 0.93
55 Chronic fatigue syndrome: a qualitative investigation of patients' beliefs about the illness. J Psychosom Res 1997 0.89
56 Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario. Clin Oncol (R Coll Radiol) 2008 0.88
57 Internet resources for psychiatry and neuropsychiatry. J Neurol Neurosurg Psychiatry 2003 0.88
58 Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. J Crit Care 2001 0.86
59 The initial development of an item bank to assess and screen for psychological distress in cancer patients. Psychooncology 2007 0.86
60 Personality dimensions in chronic fatigue syndrome and depression. J Psychosom Res 1999 0.86
61 Are functional motor and sensory symptoms really more frequent on the left? A systematic review. J Neurol Neurosurg Psychiatry 2002 0.85
62 Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol 2011 0.84
63 Clinically relevant fatigue in recurrence-free prostate cancer survivors. Ann Oncol 2011 0.83
64 Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome. Psychol Med 2012 0.83
65 Chronic fatigue syndrome and occupational health. Occup Med (Lond) 1997 0.83
66 Screening medical patients for distress and depression: does measurement in the clinic prior to the consultation overestimate distress measured at home? Psychol Med 2013 0.82
67 Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol 2007 0.82
68 Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) 2003 0.82
69 Interpretation of symptoms in chronic fatigue syndrome. Behav Res Ther 2001 0.81
70 Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) 2003 0.81
71 The cytochrome oxidase redox state in vivo. Adv Exp Med Biol 1997 0.81
72 Emotional outcomes after stroke: factors associated with poor outcome. J Neurol Neurosurg Psychiatry 2000 0.81
73 Nitric oxide as an effector and a substrate for cytochrome c oxidase. Biochem Soc Trans 1998 0.80
74 Reactivity of nitric oxide with cytochrome c oxidase: interactions with the binuclear centre and mechanism of inhibition. J Bioenerg Biomembr 1998 0.80
75 Informing future research priorities into the psychological and social problems faced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs 2013 0.79
76 Properties and structure-function relationship of HGF-SF. EXS 1993 0.79
77 Patients whom doctors find difficult to help. An important and neglected problem. Psychosomatics 1995 0.79
78 Treatment planning and delivery evaluation of volumetric modulated arc therapy for stereotactic body radiotherapy of spinal tumours: impact of arc discretization in planning system. Technol Cancer Res Treat 2012 0.78
79 Personality change after stroke: some preliminary observations. J Neurol Neurosurg Psychiatry 2004 0.78
80 Cytochrome c oxidase control by delta pH and delta psi gradients: effects of fatty acids. Biochem Soc Trans 1995 0.78
81 An unhealthy road. J Environ Monit 1999 0.76
82 Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: a preliminary report. Transplant Proc 1996 0.76
83 Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 1998 0.76
84 Reported sequence homology between Alzheimer amyloid770 and the MRC OX-2 antigen does not predict function. Brain Res Bull 1995 0.76
85 What do medical outpatients attending a neurology clinic think about antidepressants? J Psychosom Res 2004 0.76
86 PACE trial clarification. Lancet 2012 0.75
87 Letter to the editor: response to correspondence concerning 'recovery from chronic fatigue syndrome after treatments in the PACE trial'. Psychol Med 2013 0.75
88 Cognitive behaviour therapy. Review was unsystematic. BMJ 1997 0.75
89 Cognitive behavior therapy for chronic fatigue syndrome. Am J Med 1995 0.75
90 A survey of frequent attenders at a gastroenterology clinic. J Psychosom Res 2001 0.75
91 Cognitive behavior therapy for chronic fatigue syndrome. Am J Psychiatry 1998 0.75
92 Should we buy liaison psychiatry? J R Soc Med 1996 0.75
93 PACE trial authors' reply to letter by Kindlon. BMJ 2013 0.75
94 Amnesia for childhood in patients with unexplained neurological symptoms. J Neurol Neurosurg Psychiatry 2002 0.75
95 Doctors' diagnoses and patients' perceptions. Lessons from chronic fatigue syndrome. Gen Hosp Psychiatry 1998 0.75
96 "Wheelchair" patients with nonorganic disease: a psychological inquiry. J Psychosom Res 1999 0.75
97 Smart screening. J Environ Monit 2001 0.75
98 Music therapy in the setting of a psychotherapeutic centre. Br J Med Psychol 1970 0.75
99 The science of the unclean. J Environ Monit 2001 0.75
100 Integrated medicine. Science of the art of medicine does exist. BMJ 2001 0.75
101 Double-blind, dose-response study of metaproterenol inhalant solution in children with acute asthma. J Allergy Clin Immunol 1987 0.75
102 What future for dioxins? J Environ Monit 2000 0.75
103 Steroid induction of gonadotropin surges in the immature rat. I. Priming effects of androgens. Endocrinology 1978 0.75
104 Analysts in miniature. J Environ Monit 2001 0.75
105 Unhealthy particles. J Environ Monit 2000 0.75
106 The invisible pollutant: health effects of EMFs. J Environ Monit 2000 0.75
107 Sound science or sound bytes? Europe's struggle with genetically modified crops. J Environ Monit 1999 0.75
108 Rising hormones. J Environ Monit 1999 0.75
109 Phthalates: a ban too far? J Environ Monit 2000 0.75
110 Public environmental information: access or excess? J Environ Monit 1999 0.75
111 Cannabinoids and hCG levels in patients with testicular cancer. Lancet 1983 0.75
112 Doing what comes naturally. J Environ Monit 1999 0.75
113 A 1908 systematic review of the laterality of hysterical hemiplegia. J Neurol Neurosurg Psychiatry 2003 0.75
114 Living with risk. J Environ Monit 1999 0.75
115 Controlling the dose distribution with gEUD-type constraints within the convex radiotherapy optimization framework. Phys Med Biol 2008 0.75
116 Towards sustainable pesticides. J Environ Monit 1999 0.75
117 Practice: a short sharp shock. Interview by Jean Fitchew. Nurs Mirror 1983 0.75
118 Analyst in the sky: satellite-based remote sensing. J Environ Monit 2000 0.75